SCHEMBL30135342

SCHEMBL30135342

c1ccc(Cn2ncc3cncnc32)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RECQL P46063 1/20 0.54
LMNA P02545 7/20 0.51
ALDH1A1 P00352 6/20 0.51
PKM P14618 5/20 0.51
HPGD P15428 2/20 0.51
SMN1; SMN2 Q16637 2/20 0.51
HTT P42858 1/20 0.51
POLB P06746 2/20 0.48
GPR55 Q9Y2T6 1/20 0.48
CYP1A2 P05177 4/20 0.48
CYP2C9 P11712 4/20 0.48
CYP2C19 P33261 4/20 0.48
CYP3A4 P08684 3/20 0.48
TSHR P16473 2/20 0.48
MEN1 O00255 1/20 0.48
HBB P68871 1/20 0.48
KMT2A Q03164 1/20 0.48
GAA P10253 2/20 0.47
MAPT P10636 1/20 0.47
USP2 O75604 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9982974 1.00 RECQL (0.54) RECQLLMNAALDH1A1PKMHPGD
SCHEMBL30590847 0.81 ADORA2A (0.45) ALDH1A1PKMGAA
SCHEMBL1695089 0.79 RECQL (0.60) RECQLLMNAALDH1A1PKMHPGD
SCHEMBL29616987 0.79 ADORA2A (0.47) LMNASMN1; SMN2POLBCYP1A2CYP2C19
SCHEMBL4767639 0.78 SRC (0.56)
SCHEMBL21846963 0.77 RECQL (0.54) RECQLLMNAALDH1A1PKMHPGD
SCHEMBL4767875 0.75 SRC (0.54) ALDH1A1TSHR
SCHEMBL4775071 0.75 SRC (0.55)
SCHEMBL9483669 0.74 ALDH1A1 (0.59) RECQLLMNAALDH1A1PKMHPGD
SCHEMBL2244617 0.74 XDH (0.46) RECQLLMNAALDH1A1HPGDHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4319758-A1 INHIBITING UBIQUITIN-SPECIFIC PROTEASE 1 (USP1) Forma Therapeutics, Inc. (US) 2024-02-14 EP claimed
WO-2022216820-A1 INHIBITING UBIQUITIN-SPECIFIC PROTEASE 1 (USP1) FORMA THERAPEUTICS, INC. (US) 2022-10-13 WO claimed